Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative propranolol and etodolac with or without psychological support after breast cancer surgery
MOH_2017-08-10_000705Phase 2Not yet recruiting
- Sponsor
- ד"ר ערן שרון
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of propranolol and etodolac in breast cancer, sponsored by ד"ר ערן שרון. Planned start May 2017; status: not yet recruiting.
02
Drugs
propranololetodolac
03
Conditions
breast cancer
Beyond the preview
Go deeper on MOH_2017-08-10_000705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-08-10_000705.